Flea-borne (Murine) Typhus: A Re-emerging Threat in the United States - CDC Webinar 3/27/25
Recording and slides now available
During the last 25 years, flea-borne (murine) typhus, a potentially life-threatening rickettsiosis caused by Rickettsia typhi, has re-emerged with a vengeance across multiple urban centers in the United States. This is strikingly evident in Los Angeles (LA) County where Public Health has documented a dramatic rise in cases to a record high of 187 cases in 2024.
Several vertebrate species associated with urban and peri-urban habitats, including rats, opossums, and several species of fleas, contribute to the zoonotic transmission of R. typhi to susceptible human hosts. Flea-borne (murine) typhus is treatable with antibiotics, and people who are treated early in the infection recover quickly. Severe disease that can include meningoencephalitis, myocarditis, hemophagocytic lymphohistiocytosis, or death may occur in people if treatment is delayed, or if the diagnosis is missed.
For more information, see the MMWR report on flea-borne typhus associated deaths in LA County in 2022, and the LA County typhus webpage which has data, resources for the public, and information on testing and reporting.
Given the growing impact of murine typhus across U.S. urban centers, the Centers for Disease Control and Prevention (CDC) is hosted and recorded a webinar/COCA Call (with CME/CE) for healthcare professionals: CDC COCA Call: Murine Typhus – Epidemiology, Diagnosis, Treatment, and Re-emergence in the U.S.